If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Ghrelin / GHSR pathway GH-release peptide
Batch documentation
Ask sales for the Ipamorelin COA matched to the offered batch. Review the recorded tests, specifications, and results against your QA and destination-market requirements before quotation.
Overview
Ipamorelin is a five-residue pentapeptide, sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, designed for sharp selectivity at the GHSR (ghrelin / growth-hormone secretagogue receptor). The structural feature that distinguishes it from the older and broader GHRP family (GHRP-2, GHRP-6, Hexarelin) is exactly that selectivity envelope: Ipamorelin engages GHSR while sparing the related receptors that drive cortisol, prolactin, and ACTH release. The absence of cortisol-axis activation is what makes the molecule the cleanest GH-selective option for routine 503A compounding workflows and for any research context where secondary-axis effects would contaminate the readout. For compounding pharmacy buyers, Vialdyne releases Ipamorelin acetate as a lyophilised powder against a ≥99.0% main-peak HPLC specification. The 5-residue sequence is straightforward by SPPS, so the standard batch packet centres on peak-integration RP-HPLC plus ESI-MS identity; LC-MS/MS sequence verification is available on request but is rarely the load-bearing test for a pentapeptide. Most catalogue volume is paired with a GHRH-class agonist (CJC-1295 no-DAC, Sermorelin, or Tesamorelin) in dual-pathway preparations. The canonical CJC-1295 + Ipamorelin pairing is supplied directly as a pre-blended co-lyophilised vial under the cjc-1295-ipamorelin SKU at the standard 5+5 mg fill, with non-standard ratios scoped under change-control. The companion CJC-1295 + Ipamorelin pharmacology article covers the dual-pathway rationale and the ratio considerations.
Applications & buyer fit
GH-axis peptides ship to two main buyer types: compounding pharmacies dispensing under physician supervision, and research labs studying somatotropic-axis pharmacology. Pharmacies typically want sterile-filled vials with the full release packet (sterility, endotoxin, CCI); labs typically want loose-format lyophilized powder with sequence verification. Blends (the CJC-1295 / Ipamorelin combination is the canonical example) are usually co-lyophilized rather than solution-mixed for potency stability.
Sourced for
Buyer fit
Documentation that ships
Procurement note: For sterile-filled vials, confirm whether sterility, endotoxin, and CCI are included in the agreed release packet. For loose lyophilized powder, request the batch COA and separately scope any sequence-level evidence required by the buyer's written procedure.
Primary buyer fit: academic and contract research laboratories and 503A / 503B compounding pharmacies.
Specifications
Nasal spray listing · US inventory
Ipamorelin is also listed in this catalog as a nasal spray solution.

Batch COAs and test reports
Each picture is a low-resolution preview of a report's first page, with batch and report numbers covered. For the full, clear report, ask our sales team, naming the product and strength.
Batch COAIpamorelin 2 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAIpamorelin 5 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Batch COAIpamorelin 10 mg
HPLC purity · MS identity
Batch COA
Full, clear copy from sales
Independent test fails? Full refund. How it works
Browse all COAs and reportsRegulatory note
Sold as a pharmaceutical-grade active for research and for compounding-pharmacy formulation where local regulations permit (notably 503A / 503B in the United States and analogous regimes elsewhere). Not a finished dosage form. Sterile-filled vials are available with full release documentation; the buyer is responsible for verifying scheduling and dispense requirements in the destination market.
Selected literature
Frequently asked questions
For a pentapeptide of this size the identity and purity package is straightforward. Ask for an RP-HPLC chromatogram with integrated main-peak area, ESI-MS confirming the expected pentapeptide mass, and either amino-acid analysis or peptide-mapping to verify sequence integrity. Water content and counter-ion (typically acetate or trifluoroacetate) belong on the same certificate, since residual counter-ion affects your net-peptide accounting. Ask sales for the batch COA matched to the offered or supplied lot; procurement can use the actual reported results and any documented re-test date in its receiving plan.
Because the finished preparation is an injectable, the incoming active needs bacterial-endotoxin and bioburden data before it enters a sterile workflow. For any 503A scope we recommend adding LAL endotoxin per USP <85> and microbial-limits testing per USP <61>/<62> to the same released lot, so the pharmacy is not extrapolating from a different batch. The lyophilised powder should stay sealed at -20 C until the compounding session; reconstitution into bacteriostatic water happens inside the sterile field, and the smallest workable single-use aliquots are drawn immediately to keep thaw exposure at three cycles or fewer.
Yes. Ipamorelin is listed as a nasal spray solution (2 mg, 5 mg, 10 mg), filled in 10 mL or 20 mL bottles, with an MOQ of 10 bottles per content and fill. It is dispatched within the United States from US inventory; send an inquiry for current availability.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
Modified GRF 1-29 · GHRH analog
Nasal spray listed
29-mer
GHRH 1-29 fragment
Nasal spray listedCapsules listed
GH-axis blend (CJC-1295 no DAC + Ipamorelin)